Abstract
The discovery of dopamine’s occurrence in mammalian brain took place in the late fifties, between the years 1957 and 1959. Until then, dopamine stood in the shadow of the two other, at that time more prominent, catecholamines, noradrenaline and adrenaline. Even the name “dopamine” was, at the time of the amine’s discovery in the mammalian brain, still new and little known; it seems to have been proposed in about 1951 by Sir Henry Dale (see footnote, p.443, in Blaschko, 1952).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Andén, N.-E., Carlsson, A., Dahlström, A., Fuxe, K., Hillarp, N.-A. and Larsson, K. (1964a). Demonstration and mapping out of nigrostriatal dopamine neurons. Life Sci., 3, 523–530.
Andén, N.-E., Dahlström, A., Fuxe, K. and Larsson, K. (1965). Further evidence for the presence of nigro-neostriatal dopamine neurons in the rat. Am. J. Anat., 116, 329–333.
Andén, N.-E., Dahlström, A., Fuxe, K., Larsson, K., Olson, L. and Ungerstedt, U. (1966). Ascending monoamine neurons to the telencephalon and diencephalon. Acta physiol.scand., 67, 313–326.
Andén, N.-E., Ross, B.-E. and Werdinius, B. (1963). On the occurrence of homovanillic acid in brain and cerebrospinal fluid and its determination by a fluorimetric method. Life Sci., 2, 448–458.
Andén, N.-E., Ross, B.-E. and Werdinius, B. (1964b). Effects of chlorpromazine, haloperidol and reserpine on the level of phenolic acids in rabbit corpus striatum. Life Sci., 3, 149–158.
Barbeau, A. (1960). Preliminary observations on abnormal catecholamine metabolism in basal ganglia diseases. Neurology, 10, 446–451.
Barbeau, A., Murphy, C.F. and Sourkes, T.L. (1961). Excretion of dopamine in diseases of basal ganglia. Science, 133, 1706–1707.
Barbeau, A., Sourkes, T.L. and Murphy, G.F. (1962). Les catécholamines dans la maladie de Parkinson. In Monoamines et Système Nerveux centrale. (ed. J.de Ajuriaguerra). Georg, Genève and Masson, Paris.
Barger, G. and Dale, H.H. (1910). Chemical structure and sympathomimetic action of amines. J.Physiol., 41, 19–59.
Barger, G. and Ewins, A.J. (1910). Some phenolic derivatives of β-phenylethylamine. J.Chem.Soc.(London), 97, 2253–2261.
Bernheimer, H., Birkmayer, W., Hornykiewicz, O., Jellinger, K. and Seitelberger, F. (1973). Brain dopamine and the syndrome of Parkinson and Huntington. Clinical and morphological and neurochemical correlations. J.neurol.Sci., 20, 415–455.
Bernheimer, H. and Hornykiewicz, O. (1965). Wirkung von Phenothiazinderivaten auf den Dopamin- (3-Hydroxytyramin-) Stoffwechsel im Nucleus caudatus. Arch.exp.Path.Pharmak., 251, 135.
Bertler, A., Carlsson, A., Rosengren, E. and Waldeck, B. (1958). A method for the fluorimetric determination of adrenaline, noradrenaline, and dopamine in tissues. Kungl.fysiogr.sällsk.Lund förh., 28, 121–123.
Bertler, A. and Rosengren, E. (1959a). Occurrence and distribution of dopamine in brain and other tissues. Experientia, 15, 10–11.
Bertler, A. and Rosengren, E. (1959b). Occurrence and distribution of catechol amines in brain. Acta physiol.scand., 47, 350–361.
Bertler, A. and Rosengren, E. (1959c). On the distribution in brain of monoamines and of enzymes responsible for their formation. Experientia, 15, 382.
Birkhäuser, H. (1940). Fermente im Gehirn geistig normaler Menschen. Helv.Chim.Acta, 23, 1071–1086.
Birkmayer, W. and Hornykiewicz, O. (1961). Der L-Dioxyphenylalanin (= DOPA)- Effekt bei der Parkinson-Akinese. Wien.Klin.Wschr., 73, 787–788.
Birkmayer, W. and Hornykiewicz, O. (1962). Der L-Dioxyphenylalanin (=DOPA)- Effekt beim Parkinson-Syndrom des Menschen: Zur Pathogenese und Behandlung der Parkinson-Akinese. Arch.Psychiat. Nervenkr., 203, 560–574.
Birkmayer, W. and Hornykiewicz, O. (1964). Weitere experimentelle Untersuchungen über L-DOPA beim Parkinson-Syndrom und Reserpin-Parkinsonismus. Arch.Psychiat.Nervenkr., 206, 367–381.
Blaschko, H. (1939). The specific action of L-dopa decarboxylase. J.Physiol., 96, 50P–51P.
Blaschko, H. (1952). Amine oxidase and amine metabolism. Pharmacol. Rev., 4, 415–458.
Blaschko, H. (1957). Metabolism and storage of biogenic amines. Experientia, 13, 9–12.
Blaschko, H. and Chrusciel, T.L. (1960). The decarboxylation of amino acids related to tyrosine and their awakening action in reserpine-treated mice. J.Physiol., 151, 272–284.
Blaschko, H., Richter, D. and Schlossmann, H. (1937). The oxidation of adrenaline and other amines. Biochem.J., 31, 2187–2196.
Bloom, F.E., Costa, E. and Salmoiraghi. G.C. (1965). Anesthesia and the responsiveness of individual neurons of the caudate nucleus of the cat to acetylcholine, norepinephrine and dopamine administered by microelectrophoresis. J.Pharmacol., 150, 244–252.
Bowman, R.L. (1959). Fluorescence and its measurement. Pharmacol. Rev., 11, 256–261.
Bowman, R.L., Caulfield, P.A. and Udenfriend, S. (1955). Spectro-photofluorometric assay through the ultraviolett and visible range. Science, 122, 32–33.
Cardot, J. (1963). Sur la présence de la dopamine dans le système nerveux et ses relations avec la Décarboxylation de la dioxyphénylalanine chez le Mollusque Helix pomatio. C.R.Acad.Sci., Paris, 257, 1364–1366.
Carlsson, A. (1959). The occurrence, distribution and physiological role of catecholamines in the nervous system. Pharmacol.Rev., 11, 490–493.
Carlsson, A. and Hillarp, N.-A. (1962). Formation of phenolic acids in brain after administration of 3,4-dihydroxyphenylalanine. Acta physiol.scand., 55, 95–100.
Carlsson, A. and Lindqvist, M. (1963). Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta pharm.tox., 20, 140–144.
Carlsson, A., Lindqvist, M. and Magnusson, T. (1957). 3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists. Nature, 180, 1200.
Carlsson, A., Lindqvist, M., Magnusson, T. and Waldeck, B. (1958). On the presence of 3-hydroxytyramine in brain. Science, 127, 471.
Carlsson, A. and Waldeck, B. (1958). A fluorimetric method for the determination of dopamine (3-hydroxytyramine). Acta physiol. scand., 44, 293–298.
Cotzias, G.C., Van Woert, M.H. and Schiffer, I.M. (1967). Aromatic amino acids and modification of Parkinsonism. New Engl.J.Med., 276, 374–379.
Curtis, D.R. and Davis, R. (1961). A central action of 5-hydroxytryptamine and noradrenaline. Nature, 192, 1083–1084.
Dagirmanjian, R., Laverty, R., Mantegazzini, P., Sharman, D.F. and Vogt, M. (1963). Chemical and physiological changes produced by arterial infusion of dihydroxyphenylalanine into one cerebral hemisphere of the cat. J.Neurochem., 10, 177–182.
Dahlström, A. and Fuxe, K. (1964). Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons. Acta physiol.scand., 62, suppl. 232.
Degkwitz, R., Frowein, R., Kulenkampff, C. and Mohs, U. (1960). Uber die Wirkungen des L-DOPA beim Menschen und deren Beeinflussung durch Reserpin, Chlorpromazin, Iproniazid und Vitamin B6. Klin.Wschr., 38, 120–123.
Dengler, H. (1957). Über das Vorkommen von Oxytyramin in der Nebenniere. Arch.exp.Path.Pharmak., 231, 373–377.
Ehringer, H. and Hornykiewicz, O. (1960). Verteilung von Noradrenalin und Dopamin (3-Hydroxytyramin) im Gehirn des Menschen und ihr Verhalten bei Erkrankungen des extrapyramidalen Systems. Klin.Wschr., 38, 1236–1239.
Eränkö, O. (1955). Distribution of fluorescing islets, adrenaline and noradrenaline in the adrenal medulla of the hamster. Acta endocr.(Kbh.), 18, 174–179.
Ernst, E.A. (1967). Mode of action of apomorphine and dexamphetamine on gnawing compulsion in rats. Psychopharmacologia, 10, 316–323.
Euler, U.S. von (1946). A specific sympathomimetic ergone in adrenergic nerve fibres (sympathin) and its relations to adrenaline and noradrenaline. Acta physiol.scand., 12, 73–97.
Euler, U.S. von (1952). Noradrenaline. Symposium sur les hormones protéiques et dérivées des protéines. No.4, IIiéme Congrés International de Biochimie.SEDES; Paris, pp.39–55; quoted from: Blaschko, H. (1954) Pharmacol.Rev., 6, 23–28.
Euler, U.S. von and Floding, I. (1955). A fluorimetric micromethod for differential estimation of adrenaline and noradrenaline. Acta physiol.scand., 33, suppl. 118, 45–56.
Euler, U.S. von and Hamberg, U. (1949). Colorimetric determination of noradrenaline and adrenaline. Acta physiol.scand., 19, 74–84.
Euler, U.S. von, Hamberg. U. and Hellner, S. (1951). β-(3:4-Dihydroxyphenyl)ethylamine (hydroxytyramine) in normal human urine. Biochem., 49, 655–658.
Everett, G.M. (1961). Some electrophysiological and biochemical correlates of motor activity and aggressive behavior. Neuro-Psychopharmacol., 2, 479–484.
Everett, G.M. and Toman, J.E.P. (1959). Mode of action of Rauwolfia alkaloids and motor activity. In Biological Psychiatry. (ed.H. K.Masserman). Grune and Stratton, New York.
Everett, G.M. and Wiegand, R.G. (1962). Central amines and behavioral states: a critique and new data. In Proc.1st Intern. Pharmacol.Meeting, vol. 8, 85–92. Pergamon Press, Oxford.
Falck, B., Hillarp, N.-A., Thieme, G. and Torp, A. (1962). Fluorescence of catecholamines and related compounds condensed with formaldehyde. J.Histochem.Cytochem., 10, 348–354.
Feldberg, W. and Vogt, M. (1948). Acetylcholine synthesis in different regions of the central nervous system. J.Physiol., 107, 372–381.
Fuxe, K. (1965). Evidence for the existence of monoamine neurons in the central nervous system. IV.Distribution of monoamine nerve terminals in the central nervous system. Acta physiol.scand., 64, suppl. 247.
Fuxe, K., Hökfelt, T. and Ungerstedt, U. (1970). Morphological and functional aspects of central monoamine neurons. In International Rev. Neurobiology. vol. 13. (eds.C.C.Pfeiffer and J.R. Smythies). Academic Press, New York, London.
Gerschenfeld, H.M. (1964). A non-cholinergic synaptic inhibition in the central nervous system of a mollusc. Nature, 203, 415–416.
Goldberg, L.I. (1972). Cardiovascular and renal actions of dopamine: potential clinical applications. Pharmacol.Rev., 24, 1–29.
Goldstein, M., Anagnoste, B., Battista, A.F., Owen, W.S. and Nakatani, S. (1969). Studies of amines in the striatum in monkeys with nigral lesions. The disposition, biosynthesis and metabolites of (3H) dopamine and (14C) serotonin in the striatum. J.Neurochem., 16, 645–653.
Goldstein, M., Anagnoste, B., Owen, W.S. and Battista, A.F. (1966). The effects of ventromedial tegmental lesions on the biosynthesis of catecholamines in the striatum. Life Sci., 5, 2171–2176.
Goodall, McC. (1951). Studies of adrenaline and noradrenaline in mammalian hearts and suprarenals. Acta physiol.scand., 24, suppl. 85.
Gurd, M.R. (1937). The physiological action of dihydroxyphenylethylamine and sympatol. Quart.J.Pharm.Pharmacol., 10, 188–211.
Hamet, R. (1931). Contribution a l’étude de la dihydroxyphényléthylamine. Arch.Int.Pharmacodyn.Thér., 40, 427–443.
Herz, A. and Zieglgänsberger, W. (1968). The influence of microelectrophoretically applied biogenic amines, cholinomimetics and procaine on synaptic excitation in the corpus striatum. Int. J.Neuropharmacol., 7, 221–230.
Holtz, P. (1950). Über die sympathicomimetische Wirksamkeit von Gehirnextrakten. Acta physiol.scand., 20, 354–362.
Holtz, P. and Credner, K. (1942). Die enzymatische Entstehung von Oxytyramin im Organismus und die physiologische Bedeutung der Dopadecarboxylase.Arch.exp.Path.Pharmak., 200, 356–388.
Holtz, P., Credner, K. and Kroneberg, G. (1947). Über das sympathicomimetische pressorische Prinzip des Harns (“Urosympathin”). Naunyn-Schmiedeb.Arch., 204, 228–243.
Holtz, P., Heise, R. and Lüdtke, K. (1938). Fermentativer Abbau von 1-Dioxyphenylalanin durch die Niere. Arch.exp.Path.Pharmak., 191, 87–118.
Hornykiewicz, O. (1958). The action of dopamine on the arterial pressure of the guinea pig. Brit.J.Pharmacol., 13, 91–94.
Hornykiewicz, O. (1963). Die topische Lokalisation und das Verhalten von Noradrenalin und Dopamin (3-Hydroxytyramin) in der Substantia nigra des normalen und Parkinson kranken Menschen. Wien. klin.Wschr., 75, 309–312.
Hornykiewicz, O. (1964). Zur Frage des Verlaufs dopaminerger Neurone im Gehirn des Menschen. Wien.klin.Wschr., 76, 834–835.
Hornykiewicz, O. (1966). Dopamine (3-hydroxytyramine) and brain function. Pharmacol.Rev., 18, 925–964.
Hornykiewicz, O. (1971). Dopamine: its physiology, pharmacology and pathological neurochemistry. In Biogenic Amines and Physiological Membranes in Drug Therapy. (eds. J.H.Biel and L.G.Abbod). Part II. Dekker, New York.
Hornykiewicz, O. (1973). Parkinson’s disease: from brain homogenate to treatment. Fed.Proc., 32, 183–190.
Kerkut, G.A. and Walker, R.J. (1961). The effects of drugs on the neurons of the snail Helix aspersa. Comp.Biochem.Physiol., 3, 143–160.
Kerkut, G.A. and Walker, R.J. (1962). The specific chemical sensitivity of Helix nerve cells. Comp.Biochem.Physiol., 7, 277–288.
Krnjević, K. and Phillis, J.W. (1963). Actions of certain amines on cerebral cortical neurons. Brit.J.Pharmacol., 20, 471–490.
Laverty, R. and Sharman, D.F. (1965). Modification by drugs of the metabolism of 3,4-dihydroxyphenylethylamine, noradrenaline and 5-hydroxytryptamine in the brain. Brit.J.Pharmacol., 24, 759–772.
MacIntosh, F.C. (1941). The distribution of acetylcholine in the peripheral and the central nervous system. J.Physiol., 99, 436–442.
Mannich, C. and Jacobsohn, W. (1910). Über Oxyphenyl-alkylamine und Dioxyphenylalkylamine. Ber.Deut.Chem.Ges., 43, 189–197.
McDonald, R.H. and Goldberg, L.I. (1963). Comparative effects of dopamine on renal and femoral blood flows. The Pharmacologist, 5, 269.
McGeer, E.G., McGeer,;P.L. and McLennan, H. (1961). The inhibitory action of 3-hydrokytyramine, gamma-aminobutyric acid (GABA) and some other compounds towards the crayfish stretch receptor neuron. J.Neurochem., 8, 36–49.
McKenzie, G.M. and Szerb, J.C. (1968). The effect of dihydroxyphenylalanine, pheniprazine, and dextroamphetamine on the in vivo release of dopamine from the caudate nucleus. J.Pharmacol., 162, 302–308.
McLennan, H. (1965). The release of dopamine from the putamen. Experientia, 21, 725–726.
Montagu, K.A. (1957). Catechol compounds in rat tissues and in brains of different animals. Nature, 180, 244–245.
Nachmansohn, D. (1939). Cholinesterase dans le système nerveux central. Bull.Soc.Chim.biol., Paris, 21, 761–796.
Pernow, B. (1953). Studies on substance P. Purification, occurrence and biological actions. Acta physiol.scand., 29, suppl. 105.
Pletscher, A. and Gey, K.F. (1962). Topographical differences in the cerebral metabolism of DL-2-C14–3,4-dihydroxyphenylalanine. Experientia, 18, 512–513.
Poirier, L.J. and Sourkes, T.L. (1965). Influence of the substantia nigra on the catecholamine content of the striatum. Brain, 88, 181–192.
Raab, W. (1943). Adrenaline and related substances in blood and tissues. Biochem.J., 37, 470–473.
Raab, W. (1948). Specific sympathomimetic substance in the brain. Am.J.Physiol., 152, 324–339.
Raab, W. and Gigee, W. (1951). Concentration and distribution of “encephalin” in the brain of humans and animals. Proc.Soc.exp. Biol., 76, 97–100.
Roos, B.-E. and Steg, G. (1964). The effect of L-3,4-dihydroxyphenylalanine and DL-5-hydroxytryptophan on rigidity and tremor induced by reserpine, chlorpromazine and phenoxybenzamine. Life Sci., 3, 351–360.
Rossum, J.M.van (1964). Significance of dopamine in psychomotor stimulant action. In Biochemical and Neurophysiological Correlations of Centrally Acting Drugs. (eds. E.Trabucchi, R. Paoletti and N.Canal). Pergamon Press, Oxford, London.
Sano, I., Gamo, T., Kakimoto, Y., Taniguchi, K., Takesada, M. and Nishinuma, K. (1959). Distribution of catechol compounds in human brain. Biochim.biophys.Acta, 32, 586–587.
Schumann, H.J. (1956). Nachweis von Oxytyramin (Dopamin) in sympathischen Nerven und Ganglien. Arch.exp.Path.Pharmak., 227, 566–573.
Seiden, L.S. and Carlsson, A. (1963). Temporary and partial antagonism by L-DOPA of reserpine-induced suppression of a conditioned avoidance response. Psychopharmacologia, 4, 418–423.
Shaw, F.H. (1938). The estimation of adrenaline. Biochem.J., 38, 19–25.
Shepherd, D.M. and West, G.B. (1953). Hydroxytyramine and the adrenal medulla. J.Physiol., 120, 15–19.
Sourkes, T.L. and Murphy, G.F. (1961). III. Determination of catecholamines and catecholamino acids by differential spectrophotofluorimetry. In Methods in Medical Research. vol. IX. (ed.J.H. Quastel). Year Book Med.Publ., Chicago.
Sourkes, T.L. and Poirier, L. (1965). Influence of the substantia nigra in the concentration of 5-hydroxytryptamine and dopamine of the striatum. Nature, 207, 202–203.
Sweeney, D. (1963). Dopamine: its occurrence in mulluscan ganglia. Science, 139, 1051.
Symposium (1966). Second Symposium on Catecholamines. Pharmacol. Rev., 18, 1–803.
Tainter, M.L. (1930). Comparative action of sympathomimetic compounds: The influence of cocaine and certain related compounds upon the action of a group of sympathomimetic amines. Quart. J.Pharmacol., 3, 584–598.
Ungerstedt, U. (1968). 6-hydroxydopamine induced degeneration of central monoamine neurons. Europ.J.Pharmacol., 5, 107–110.
Vogt, M. (1954). The concentration of sympathin in different parts of the central nervous system under normal conditions and after the administration of drugs. J.Physiol., 123, 451–481.
Weil-Malherbe, H. and Bone, A.D. (1952). Chemical estimation of adrenaline-like substances in blood. Biochem.J., 51, 311–318.
Weil-Malherbe, H. and Bone, A.D. (1957). Intracellular distribution of catecholamines in the brain. Nature, 180, 1050–1051.
Woodruff, G.N. (1971). Dopamine receptors: a review. Comp.gen. Pharmac., 2, 439–455.
Woodruff, G.N. and Walker, R.J. (1969). The effect of dopamine and other compounds on the activity of neurones of Helix aspersa; structure-activity relationships. Int.J.Neuropharmacol., 8, 279–289.
Zeller, E.A. and Barsky, J. (1952). In vivo inhibition of liver and brain monoamine oxidase by 1-isonicotinyl-2-isopropyl hydrazine. Proc.Soc.exp.Biol.Med., 81, 459.
Editor information
Editors and Affiliations
Copyright information
© 1986 The Contributors
About this chapter
Cite this chapter
Hornykiewicz, O. (1986). A Quarter Century of Brain Dopamine Research. In: Woodruff, G.N., Poat, J.A., Roberts, P.J. (eds) Dopaminergic Systems and their Regulation. Satellite Symposia of the IUPHAR 9th International Congress of Pharmacology. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-07431-0_1
Download citation
DOI: https://doi.org/10.1007/978-1-349-07431-0_1
Publisher Name: Palgrave Macmillan, London
Print ISBN: 978-1-349-07433-4
Online ISBN: 978-1-349-07431-0
eBook Packages: MedicineMedicine (R0)